Velleca Mark A. - Insider Non-Derivative Transactions at Black Diamond Therapeutics, Inc. (BDTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 15, 2023, Velleca Mark A.'s relationship to Black Diamond Therapeutics, Inc. (BDTX) is Director,Officer (PRESIDENT & CEO), and currently has 46,522 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BDTX insiders.
Data Source: SEC.
Velleca Mark A. - Insider Non-Derivative Transactions of BDTX Common Stock
Velleca Mark A. - Insider Non-Derivative Transactions at BDTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 16, 2023 | Acquisition -- (Common Stock) | 5208 | 3.6 | 46522 |
| Jun 17, 2023 | Acquisition -- (Common Stock) | 8929 | 2.1 | 41314 |
| Mar 17, 2023 | Acquisition -- (Common Stock) | 11228 | 1.67 | 32385 |